Latest Production Development News

Starpharma has entered a landmark collaboration with Genentech to develop innovative cancer therapies using its proprietary DEP® platform, securing $5.5 million upfront and potential milestones exceeding $560 million.

Activeport Group Ltd has successfully raised $6.68 million through a two-tranche placement, positioning the company to accelerate its software development and target cash flow positivity in FY26.

Wellnex Life Limited has expanded its financing with a new A$2.5 million loan facility, enhancing its financial flexibility to support ongoing business growth and settle long-term obligations.

Aspermont Limited has raised an additional $891,210 through its Share Purchase Plan, complementing a recent $1.75 million institutional placement. This capital injection supports the company’s strategic pivot towards data-driven mining intelligence and AI-powered services.

Advanced Health Intelligence has appointed Dylan Garnett as its new CEO, signaling a strategic pivot towards commercialisation and revenue growth. Garnett’s extensive background in healthcare, insurance, and digital health positions AHI for its next growth phase.

Jatcorp has officially appointed Dr Xinpeng (Sean) Li as its CEO, locking in a three-year contract that underscores a strategic focus on sustainable growth and innovation.

OMG Group has significantly expanded its Oat Milk Goodness PrOATein ready-to-drink range to nearly 1,000 Woolworths stores nationwide, backed by a recent $2 million capital raise and plans for new product launches.

EVE Health Group has appointed Dr Fiona Cousins as the inaugural member of its Scientific Advisory Board, reinforcing its commitment to advancing treatments for dysmenorrhoea and endometriosis ahead of the commercial launch of Dyspro™.

TZ Limited appoints Antonino Schiavello as Non-Executive Director and partners with his Nura Space venture to accelerate workplace technology solutions, while securing a $750,000 credit extension to support product delivery.

Artrya Limited has raised A$75 million through a two-tranche placement and launched a A$5 million share purchase plan to fast-track the U.S. commercialisation of its AI-powered Salix platform following FDA clearance.

Felix Group Holdings reminds shareholders that its Share Purchase Plan closes on 9 September, offering shares at a slight discount following a $16 million placement. Eligible investors in Australia and New Zealand have a final chance to participate without brokerage fees.

The Calmer Co. reports a significant operational turnaround in H2 FY25, with sales momentum building through July and August, driven by cost reductions and new product launches in the US market.